Edward Felix
- Molecular Biology
- Biochemistry top 2%
- Pharmacology top 10%
- Cancer Research
- Oncology
- Co-authors
- Robert A. NewmanPeiying YangTimothy MaddenGordon B. MillsDiana ChanSusan M. FischerCarrie CartwrightD H Ho
- Topics
- Eicosanoids and Hypertension Pharmacology (6 papers)Inflammatory mediators and NSAID effects (6 papers)Acute Myeloid Leukemia Research (4 papers)
- Partner nations
- United StatesUnited KingdomJapan
In The Last Decade
Edward Felix
29 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 96
- Molecular Biology 600
- Biochemistry 219
- Pharmacology 164
- Cancer Research 153
- Oncology 117
Countries citing papers authored by Edward Felix
This map shows the geographic impact of Edward Felix's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward Felix with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward Felix more than expected).
Fields of papers citing papers by Edward Felix
This network shows the impact of papers produced by Edward Felix. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward Felix. The network helps show where Edward Felix may publish in the future.
Co-authorship network of co-authors of Edward Felix
This figure shows the co-authorship network connecting the top 25 collaborators of Edward Felix. A scholar is included among the top collaborators of Edward Felix based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edward Felix. Edward Felix is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 52 | |
| 2 | 14 | |
| 3 | 18 | |
| 4 | Determinants of human and mouse melanoma cell sensitivities to oleandrin. | 23 |
| 5 | 86 | |
| 6 | 71 | |
| 7 | Oleandrin-mediated oxidative stress in human melanoma cells. | 72 |
| 8 | An LC/MS/MS based method to analyze tissue eicosanoids: Application to EPA-mediated alteration of prostaglandin metabolism | 1 |
| 9 | 93 | |
| 10 | 22 | |
| 11 | The human lipid phosphate phosphatase-3 decreases the growth, survival, and tumorigenesis of ovarian cancer cells: validation of the lysophosphatidic acid signaling cascade as a target for therapy in ovarian cancer. | 124 |
| 12 | 66 | |
| 13 | 34 | |
| 14 | 99 | |
| 15 | Persistence of self-renewing leukemia cell progenitors during remission in children with B-precursor acute lymphoblastic leukemia. | 26 |
| 16 | 4 | |
| 17 | 6 | |
| 18 | 2 | |
| 19 | 16 | |
| 20 | 2 |
About Edward Felix
Edward Felix is a scholar working on Biochemistry, Pharmacology and Cancer Research, having authored 29 papers that have together received 1.0k indexed citations. Recurring topics across this work include Eicosanoids and Hypertension Pharmacology (6 papers), Inflammatory mediators and NSAID effects (6 papers) and Acute Myeloid Leukemia Research (4 papers). The work is most often cited by research in Biochemistry (219 citations), Cancer Research (153 citations) and Pharmacology (164 citations). Edward Felix has collaborated with scholars based in United States, United Kingdom and Japan. Frequent co-authors include Robert A. Newman, Peiying Yang, Timothy Madden, Gordon B. Mills, Diana Chan, Susan M. Fischer, Carrie Cartwright, D H Ho, Esther C. Kempen and Russell D. Klein. Their work appears in journals such as Blood, Cancer Research and Analytical Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.